Profile data is unavailable for this security.
About the company
Evolva Holding Ltd is a Switzerland-based Company operating as a researcher for biotechnology. The Company develops and commercializes nature-based ingredients. The ingredients, produced by the Company, can be employed in, but not limited to, flavorings fragrancies, health ingredients, health protection and other various sectors. The objectives of the Company are as follows: develop technology platforms - combines biology with technology to produce nature-based ingredients; provide technology services- provides tailored services to clients across industries. The Company is focused on developing and increasing the return and effectiveness of the production of numerous ingredients within their portfolio.
- Revenue in CHF (TTM)4.16m
- Net income in CHF-101.22m
- Incorporated1997
- Employees49.00
- LocationEvolva Holding LtdDuggingerstrasse 23REINACH 4153SwitzerlandCHE
- Phone+41 614852000
- Fax+41 614852001
- Websitehttps://www.evolva.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Modus Therapeutics Holding AB | 0.00 | -1.24m | 5.21m | 2.00 | -- | 4.31 | -- | -- | -0.7495 | -0.7495 | 0.00 | 0.4056 | 0.00 | -- | -- | 0.00 | -128.10 | -141.06 | -502.76 | -278.44 | -- | -- | -- | -- | -- | -11.79 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
| Theranexus SA | 0.00 | -6.60m | 5.42m | 19.00 | -- | 2.52 | -- | -- | -1.09 | -1.09 | 0.00 | 0.2863 | 0.00 | -- | -- | 0.00 | -70.79 | -42.66 | -82.29 | -47.97 | -- | -- | -- | -- | -- | -1,058.68 | 0.6212 | -- | -- | -- | -3.97 | -- | -33.23 | -- |
| Chosa Oncology AB | 6.04k | -738.18k | 5.58m | -- | -- | 3.75 | -- | 923.25 | -0.8644 | -0.8644 | 0.0017 | 0.2532 | 0.0024 | -- | 0.0103 | -- | -29.49 | -51.96 | -44.69 | -61.92 | -- | -- | -12,217.81 | -708.47 | -- | -1,453.67 | 0.00 | -- | -98.21 | -- | 28.33 | -- | -- | -- |
| PCI Biotech Holding ASA | 242.04k | -1.64m | 5.59m | 7.00 | -- | 1.77 | -- | 23.09 | -0.5443 | -0.5443 | 0.0801 | 1.05 | 0.0556 | -- | 0.6848 | 427,142.80 | -37.78 | -36.44 | -41.97 | -40.14 | -- | -- | -679.43 | -1,055.43 | -- | -- | 0.0081 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
| Abera Bioscience AB | 0.00 | -1.05m | 5.72m | 6.00 | -- | 7.02 | -- | -- | -0.9261 | -0.9261 | 0.00 | 0.6407 | 0.00 | -- | -- | 0.00 | -90.08 | -79.42 | -117.23 | -96.10 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 13.74 | -- | -- | -- |
| Dextech Medical AB | 0.00 | -374.71k | 6.12m | 1.00 | -- | 2.39 | -- | -- | -0.2449 | -0.2449 | 0.00 | 1.67 | -- | -- | -- | -- | -- | -28.96 | -- | -29.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.89 | -- | 0.412 | -- |
| Quantum Genomics SA | 9.73k | -3.07m | 6.47m | 3.00 | -- | 7.66 | -- | 665.22 | -0.091 | -0.091 | 0.0003 | 0.0125 | 0.0007 | -- | 0.0016 | 3,353.33 | -23.14 | -60.77 | -95.19 | -102.24 | -14,205.07 | -3,548.91 | -31,520.38 | -3,374.13 | -- | -146.53 | 0.8615 | -- | -98.34 | -- | 87.28 | -- | -- | -- |
| Evolva Holding Ltd | 4.16m | -101.22m | 7.00m | 49.00 | -- | 1.26 | -- | 1.68 | -14.04 | -14.04 | 0.7083 | 0.77 | 0.0685 | -- | 1.91 | -- | -166.87 | -37.51 | -190.97 | -41.07 | -23.54 | -- | -2,434.99 | -818.05 | -- | 0.4155 | 0.00 | -- | 517.55 | -14.19 | -22.13 | -- | -- | -- |
| Sprint Bioscience AB | 5.66m | 725.93k | 7.73m | 36.00 | 10.65 | 3.78 | 10.02 | 1.37 | 0.1256 | 0.1256 | 0.9791 | 0.3538 | 1.58 | -- | 11.45 | 2,441,286.00 | 20.29 | -71.22 | 43.20 | -113.71 | 80.06 | 62.75 | 12.83 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Milestone Medical Inc | 6.59k | -3.14m | 7.89m | 4.00 | -- | -- | -- | 1,196.52 | -0.6308 | -0.6308 | 0.0013 | -5.07 | 0.0109 | 0.5918 | 0.1213 | -- | -517.54 | -340.87 | -- | -- | -3,337.03 | -166.46 | -47,612.84 | -5,029.09 | 0.0067 | -34.89 | -- | -- | -65.34 | 92.41 | -16.23 | -- | -- | -- |
| Genflow Biosciences PLC | 0.00 | -1.87m | 8.05m | 5.00 | -- | 8.06 | -- | -- | -0.0056 | -0.0056 | 0.00 | 0.0025 | 0.00 | -- | -- | 0.00 | -88.30 | -- | -105.34 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -21.97 | -- | -- | -- |
| Acticor Biotech SA | 0.00 | -18.03m | 8.38m | 28.00 | -- | -- | -- | -- | -1.55 | -1.55 | 0.00 | -0.4028 | 0.00 | -- | -- | 0.00 | -164.53 | -- | -568.29 | -- | -- | -- | -- | -- | -- | -19.85 | 10.47 | -- | -- | -- | -17.40 | -- | -- | -- |
| GENOMED SA | 4.92m | 103.16k | 8.49m | 44.00 | 82.27 | 3.97 | 36.08 | 1.73 | 0.3452 | 0.3452 | 16.45 | 7.15 | 2.06 | 5.94 | 11.85 | 493,900.20 | 4.33 | 7.77 | 4.82 | 9.19 | 42.78 | 38.53 | 2.10 | 3.87 | 5.00 | 1,435.88 | 0.00 | -- | 9.88 | 3.88 | 174.07 | -8.94 | -32.19 | -- |
| Medicofarma Biotech SA | 307.30k | -650.41k | 8.61m | -- | -- | 3.84 | -- | 28.02 | -0.0423 | -0.0423 | 0.02 | 0.1459 | 0.0866 | 5.56 | 2.83 | -- | -18.34 | -15.05 | -23.49 | -18.17 | 78.54 | 29.92 | -211.65 | -42.86 | 0.805 | -16.98 | 0.00 | -- | -82.34 | -31.48 | -116.39 | -- | -- | -- |
| AroCell AB (publ) | 3.71m | -4.65m | 8.77m | -- | -- | 0.6919 | -- | 2.37 | -0.2437 | -0.2437 | 0.1944 | 0.6648 | 0.2325 | 5.82 | 5.63 | -- | -29.14 | -29.25 | -31.00 | -31.37 | 1.88 | -9.85 | -125.33 | -231.19 | 5.16 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
Data as of Jul 24 2024. Currency figures normalised to Evolva Holding Ltd's reporting currency: Swiss Franc CHF
2.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Credit Suisse Asset Management (Schweiz) AGas of 28 Jun 2024 | 56.57k | 0.78% |
| UBS Asset Management Switzerland AGas of 02 Jul 2024 | 34.81k | 0.48% |
| Z�rcher Kantonalbank (Investment Management)as of 31 May 2024 | 31.34k | 0.43% |
| Credit Suisse AGas of 31 May 2024 | 7.22k | 0.10% |
| BlackRock Asset Management Schweiz AGas of 04 Jul 2024 | 6.34k | 0.09% |
| Picard Angst AGas of 30 Jun 2023 | 4.18k | 0.06% |
| DWS CH AGas of 31 May 2024 | 2.97k | 0.04% |
| Quorus Verm�gensverwaltung AGas of 29 May 2024 | 800.00 | 0.01% |
| BlackRock Advisors (UK) Ltd.as of 31 Jul 2023 | 720.00 | 0.01% |
| State Street Global Advisors France SAas of 31 May 2024 | 476.00 | 0.01% |
More ▼
Data from 30 Jun 2023 - 18 Jul 2024Source: FactSet Research Systems Inc.
